Hemoglobin-based oxygen carrier mitigates transfusion-mediated pancreas cancer progression

Annals of Surgical Oncology

Volumn 20, Issue 6, 2013, Pages 2073-2077

  Lo, Karen K ^a,d   Bey, Erik A ^c   Patra, Biswantha ^c   Benson, Douglas D ^a,d   Boothman, David A ^c   Silliman, Christopher C ^a,d   Barnett Jr , Carlton C ^a,b,d  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; HEMOGLOBIN; HEMOGLOBIN BASED OXYGEN CARRIER; PLATELET DERIVED GROWTH FACTOR BB; RANTES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; IMMUNOCOMPETENCE; IN VIVO STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; MORBIDITY; MOUSE; NONHUMAN; PANCREAS CANCER; PERITONEUM METASTASIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD SUBSTITUTES; CHEMOKINE CCL5; CYTOKINES; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; MICE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PLASMA; PROTEIN ARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS C-SIS;

EID: 84878214078     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2842-0     Document Type: Article

References (20)

1. American Red Cross Blood Facts and Statistics. 2006.
2. Opelz G, Teraski P. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978;299: 799-803.
3. Gantt C. Red blood cells for cancer patients. Lancet. 1981;2: 363.
4. Yeh JJ GM, Tomlinson JS, Idrees K, Brennan MF, Fong Y. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg. 2007;94: 466-472.
5. Park SJ KS, Jang JY, Lee KU, Park YH. Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy? World J Surg. 2002;26: 487-492.
6. Barnett CC, Jr., Beck AW, Holloway SE, et al. Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice. Cancer. 2010;116: 3862-3874.
7. Yao HS, Wang Q, Wang WJ, Hu ZQ. Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis. World J Surg. 2008;32: 2038-2046.
8. Technical Manual. American association of blood banks, Bethesda. 2003.
9. Silliman CC, Clay KL, Thurman GW et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124: 684-694.
10. Holloway S, Davis M, Jaber R, Fleming J. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway. Int J Gastrointest Cancer. 2003;33: 61-69.
11. Contag CH, Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Ann Rev Biomed Eng. 2002;4: 235-260.
12. Animal resources body weight study of 1993. In: The Jackson Labs 1993.
13. Morikawa K, Walker SM, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 1988;48: 1943-1948.
14. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 1994;124: 684-694.
15. Partrick DA, Moore FA, Moore EE, et al. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horizons. 1996;4: 194-210.
16. Johnson JL, Moore EE, Gonzalez RJ, et al. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. J Trauma. 2003;54: 133-139; discussion 139-140.
17. Johnson JL, Moore EE, Offner PJ, et al. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma. 2001;50: 449-455; discussion 456.
18. Silliman C, Kelher M, Masuno T, Moore EE, Damle S, Cheng A. A two-event in vivo model of transfusion-related acute lung injury. Blood. 2006;108(suppl): 10a.
19. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003;43: 633-640.
20. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101: 1458-1467.